+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Polymeric Biomaterials Market Size, Share & Trends Analysis Report by Product (Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polyurethane), Application, Region, and Segment Forecasts, 2024-2030

  • PDF Icon

    Report

  • 170 Pages
  • November 2023
  • Region: Global
  • Grand View Research
  • ID: 5846774
Description Jump to:
The global polymeric biomaterials market size is anticipated to reach USD 148.87 billion by 2030, according to the report. The market is expected to expand at a CAGR of 16.54% from 2024 to 2030. The growth is attributed to the rising product innovations, increasing applications of polymeric biomaterials in tissue engineering, and the growing need for polymeric biomaterials in surgical procedures.

Increasing demand for polymeric biomaterials in the field of regenerative medicine is fueling market growth. Polymeric biomaterials such as injectable hydrogels act as a promising solution for the rising demand for minimally invasive cell delivery systems owing to the ability to undergo a flexible sol-gel transition and adaptively fill defects, enabling minimally invasive interventions.Furthermore, several synthetic polymers, such as Poly (lactic-co-glycolic acid) (PLGA), Polyethylene Glycol (PEG), and Polycaprolactone (PCL), are widely utilized in cell delivery applications. Similarly, composite hydrogels incorporating inorganic constructs have also been investigated for their potential in facilitating minimally invasive cell delivery for tissue repair purposes.

The COVID-19 pandemic adversely affected the market in due to several lockdown strictures, hindrances in supply chain operations, and decreased clinical research activities.Despite the negative impact, the market is expected to witness strong growth prospects in the long term due to the increasing adoption of polymeric biomaterials for devising new therapeutic strategies for COVID-19 treatment. For instance, according to an article published in the Emergent Materials Journal in April 2021, biomaterial substances were studied for the controlled delivery of drugs, such as interleukin 6 (IL-6) inhibitors, for COVID-19 treatment. As a result, with the increasing demand for novel therapeutics for COVID-19, the market is expected to witness significant growth in the coming years.

Furthermore, key players in the industry are adopting various strategies such as acquisitions, collaborations, partnerships, expansions and new product launches to strengthen their market position and expand their customer base. For instance, in January 2023, MicroPort Scientific Corporation received marketing approval for its Firehawk Liberty Rapamycin Target Eluting Coronary Stent System in Russia. This approval is anticipated to expand the company’s geographical presence. Moreover, in July 2022, Corbion collaborated with STENTiT and Vivolta for the development of a regenerative stent for clinical use and treatment of patients suffering from critical limb ischemia. This increasing adoption of strategies by major companies are anticipated to drive market growth from 2023 to 2030.

Polymeric biomaterials lack mechanical strength and stability as compared to other biomaterial substances. Hence, for applications with high strength, durability, or load-bearing capabilities, it may find limited usage. However, increasing investment in the technological advancement of polymeric biomaterials by major players is anticipated to mitigate this challenge over the forecast period.

Polymeric Biomaterials Market Report Highlights

  • Based on the product, the Polylactic Acid (PLA) segment held the largest market share of 20.85% in 2023. The segment growth is attributed to the wide application of several types of PLA blends in the field of drug delivery, manufacturing of implants & sutures, and tissue engineering applications
  • Based on the application, the orthopedic segment dominated the market with a share of 23.49% in 2023. The segment growth is attributed to the growing incidence of orthopedic diseases, which in turn, is encouraging scientists to discover novel and more effective treatment options using polymeric biomaterials
  • North America held the largest market share of 38.49% in 2023, owing to a rise in the number of surgical procedures for orthopedic injuries and cosmetic surgeries and the need for sustainable biomaterials

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.2 Market Definitions
1.2.1 Information Analysis
1.2.2 Market Formulation & Data Visualization
1.2.3 Data Validation & Publishing
1.3 Research Assumptions
1.4 Information Procurement
1.4.1 Primary Research:
1.5 Information or Data Analysis
1.6 Market Formulation & Validation
1.7 Market Model
1.8 Global Market: CAGR Calculation
1.9 Objectives
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, and Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Market Trends & Outlook
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Rising Demand For Polymeric Biomaterials For Minimally Invasive Applications
3.3.1.2 Advancements In Biomaterials Technologies
3.3.1.3 Expansion In The Scope Of Applications For Biomaterials
3.3.2 Market Restraint Analysis
3.3.2.1 High expenses associated with the development and commercialization of biomaterials
3.3.2.2 Problems related to mechanical strength and stability of polymeric biomaterials
3.4 Business Environment Analysis
3.4.1 Pestel Analysis
3.4.2 Porter’s Five Forces Analysis
3.5 COVID-19 Impact Analysis
Chapter 4 Product Business Analysis
4.1 Polymeric Biomaterials Market: Product Movement Analysis
4.2 Polylactic Acid (PLA)
4.2.1 Global Polylactic Acid (PLA) Market, 2018 - 2030 (USD Million)
4.3 Polyglycolic Acid (PGA)
4.3.1 Global Polyglycolic Acid (PGA) Market, 2018 - 2030 (USD Million)
4.4 Polyurethanes
4.4.1 Global Polyurethanes Market, 2018 - 2030 (USD Million)
4.5 Polytetrafluoroethylene (PTFE) & Expanded Polytetrafluoroethylene (ePTFE)
4.5.1 Global Polytetrafluoroethylene (Ptfe) & Expanded Polytetrafluoroethylene (Eptfe) Market, 2018 - 2030 (USD Million)
4.6 Polyaryletheretherketone (PEEK)
4.6.1 Global Polyaryletheretherketone (PEEK) Market, 2018 - 2030 (USD Million)
4.7 Polydioxanone (Pdo)
4.7.1 Global Polydioxanone (Pdo) Market, 2018 - 2030 (USD Million)
4.8 Others
4.8.1 Global Other Products Market, 2018 - 2030 (USD Million)
Chapter 5 Application Business Analysis
5.1 Polymeric Biomaterials Market: Application Movement Analysis
5.2 Cardiovascular
5.2.1 Global Cardiovascular Market, 2018 - 2030 (USD Million)
5.2.2 Bioresorbable Stents
5.2.2.1 Global Bioresorbable Stents Market, 2018 - 2030 (USD Million)
5.2.3 Vascular Grafts
5.2.3.1 Global Vascular Grafts Market, 2018 - 2030 (USD Million)
5.2.4 Sensors
5.2.4.1 Global Sensors Market, 2018 - 2030 (USD Million)
5.2.5 Guidewires
5.2.5.1 Global Guidewires Market, 2018 - 2030 (USD Million)
5.2.6 Implantable Cardiac Defibrillators
5.2.6.1 Global Implantable Cardiac Defibrillators Market, 2018 - 2030 (USD Million)
5.2.7 Pacemakers
5.2.7.1 Global Pacemakers Market, 2018 - 2030 (USD Million)
5.2.8 Others
5.2.8.1 Global Others Market, 2018 - 2030 (USD Million)
5.3 Dental
5.3.1 Global Dental Market, 2018 - 2030 (USD Million)
5.3.2 Tissue Regeneration Materials
5.3.2.1 Global Tissue Regeneration Market, 2018 - 2030 (USD Million)
5.3.3 Dental Implants
5.3.3.1 Global Dental Implants Market, 2018 - 2030 (USD Million)
5.3.4 Bone Grafts & Substitutes
5.3.4.1 Global Bone Graft & Substitutes Market, 2018 - 2030 (USD Million)
5.3.5 Dental Membranes
5.3.5.1 Global Dental Membranes Market, 2018 - 2030 (USD Million)
5.3.6 Dental Sutures
5.3.6.1 Global Dental Sutures Market, 2018 - 2030 (USD Million)
5.3.7 Others
5.3.7.1 Global others market, 2018 - 2030 (USD Million)
5.4 Plastic Surgery
5.4.1 Global Plastic Surgery Market, 2018 - 2030 (USD Million)
5.4.2 Facial Wrinkle Treatment
5.4.2.1 Global Facial Wrinkle Treatment Market, 2018 - 2030 (USD Million)
5.4.3 Soft Tissue Fillers
5.4.3.1 Global Soft Tissue Fillers Market, 2018 - 2030 (USD Million)
5.4.4 Craniofacial Surgery
5.4.4.1 Global Craniofacial Surgery Market, 2018 - 2030 (USD Million)
5.4.4.2 Sutures
5.4.4.2.1 Global Sutures Market, 2018 - 2030 (USD Million)
5.4.4.3 Others
5.4.4.3.1 Others Market, 2018 - 2030 (USD Million)
5.4.5 Bioengineered Skins
5.4.5.1 Global Bioengineered Skins Market, 2018 - 2030 (USD Million)
5.4.6 Peripheral Nerve Repair
5.4.6.1 Global Peripheral Nerve Repair Market, 2018 - 2030 (USD Million)
5.4.7 Acellular Dermal Matrices
5.4.7.1 Global Acellular Dermal Matrices Market, 2018 - 2030 (USD Million)
5.4.8 Others
5.4.8.1 Global others market, 2018 - 2030 (USD Million)
5.5 Neurology
5.5.1 Global Neurology Market, 2018 - 2030 (USD Million)
5.5.2 Neural Stem Cell Encapsulation
5.5.2.1 Global Neural Stem Cell Encapsulation Market, 2018 - 2030 (USD Million)
5.5.3 Shunting Systems
5.5.3.1 Global Shunting Systems Market, 2018 - 2030 (USD Million)
5.5.4 Hydrogel Scaffold
5.5.4.1 Global Hydrogel Scaffold Market, 2018 - 2030 (USD Million)
5.5.5 Cortical Neural Prosthetics
5.5.5.1 Global Cortical Neural Prosthetics Market, 2018 - 2030 (USD Million)
5.5.6 Others
5.5.6.1 Global others market, 2018 - 2030 (USD Million)
5.6 Orthopedic
5.6.1 Global Orthopedic Market, 2018 - 2030 (USD Million)
5.6.2 Joint Replacement Polymeric Biomaterials
5.6.2.1 Global Joint Replacement Biomaterials Market, 2018 - 2030 (USD Million)
5.6.3 Tissue Fixation Products
5.6.3.1 Global Tissue Fixation Products Market, 2018 - 2030 (USD Million)
5.6.3.2 Sutures
5.6.3.2.1 Global Sutures Market, 2018 - 2030 (USD Million)
5.6.3.3 Other
5.6.3.3.1 Global Other Market, 2018 - 2030 (USD Million)
5.6.4 Orthobiologics
5.6.4.1 Global Orthobiologics Market, 2018 - 2030 (USD Million)
5.6.5 Viscosupplementation
5.6.5.1 Global Viscosupplementation Market, 2018 - 2030 (USD Million)
5.6.6 Spine Biomaterials
5.6.6.1 Global Spine Biomaterials Market, 2018 - 2030 (USD Million)
5.6.7 Others
5.6.7.1 Global others market, 2018 - 2030 (USD Million)
5.7 Other Application
5.7.1 Global Other Applications Market, 2018 - 2030 (USD Million)
Chapter 6 Regional Business Analysis
6.1 North America
6.1.1 North America Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.1.2 U.S.
6.1.2.1 Key country dynamics
6.1.2.2 U.S. polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.1.2.3 Market scenario
6.1.2.4 Regulatory framework
6.1.2.5 Disease prevalence
6.1.3 Canada
6.1.3.1 Key country dynamics
6.1.3.2 Canada polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.1.3.3 Market scenario
6.1.3.4 Regulatory framework
6.1.3.5 Disease prevelance
6.2 Europe
6.2.1 Europe Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.2 Germany
6.2.2.1 Key country dynamics
6.2.2.2 Germany polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.2.3 Market scenario
6.2.2.4 Regulatory framework
6.2.2.5 Disease prevelance
6.2.3 UK
6.2.3.1 Key country dynamics
6.2.3.2 UK polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.3.3 Market scenario
6.2.3.4 Regulatory framework
6.2.3.5 Disease Prevelance
6.2.4 France
6.2.4.1 Key Country Dynamics
6.2.4.2 France Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.4.3 Market Scenario
6.2.4.4 Regulatory Framework
6.2.4.5 Disease Prevalence
6.2.5 Italy
6.2.5.1 Key country dynamics
6.2.5.2 Italy polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.5.3 Market scenario
6.2.5.4 Regulatory framework
6.2.5.5 Disease prevelance
6.2.6 Spain
6.2.6.1 Key country dynamics
6.2.6.2 Spain polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.6.3 Market scenario
6.2.6.4 Regulatory framework
6.2.6.5 Disease prevelance
6.2.7 Denmark
6.2.7.1 Key Country Dynamics
6.2.7.2 Denmark Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.7.3 Market Scenario
6.2.7.4 Regulatory Framework
6.2.7.5 Disease Prevelance
6.2.8 Sweden
6.2.8.1 Key Country Dynamics
6.2.8.2 Sweden Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.2.8.3 Market Overview
6.2.8.4 Regulatory Framework
6.2.8.5 Disease Prevelance
6.2.9 Norway
6.2.9.1 Key country dynamics
6.2.9.2 Norway polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.2.9.3 Market scenario
6.2.9.4 Regulatory framework
6.2.9.5 Disease prevelance
6.3 Asia Pacific
6.3.1 Asia Pacific Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.2 JAPAN
6.3.2.1 Key country dynamics
6.3.2.2 Japan polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.2.3 Market overview
6.3.2.4 Regulatory framework
6.3.2.5 Disease prevelance
6.3.3 China
6.3.3.1 Key Country Dynamics
6.3.3.2 China Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.3.3 Market Scenario
6.3.3.4 Regulatory Framework
6.3.3.5 Disease Prevelance
6.3.4 India
6.3.4.1 Key country dynamics
6.3.4.2 India polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.4.3 Market scenario
6.3.4.4 Regulatory framework
6.3.4.5 Disease prevelance
6.3.5 Australia
6.3.5.1 Key Country Dynamics
6.3.5.2 Australia Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.5.3 Market Scenario
6.3.5.4 Regulatory Framework
6.3.5.5 Disease Prevelance
6.3.6 Thailand
6.3.6.1 Key country dynamics
6.3.6.2 Thailand polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.3.6.3 Market Scenario
6.3.6.4 Regulatory Framework
6.3.6.5 Disease Prevelance
6.3.7 South Korea
6.3.7.1 Key Country Dynamics
6.3.7.2 South Korea Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.3.7.3 Market scenario
6.3.7.4 Regulatory framework
6.3.7.5 Disease prevelance
6.4 Latin America
6.4.1 Latin America Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.2 Brazil
6.4.2.1 Key country dynamics
6.4.2.2 Brazil polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.2.3 Market scenario
6.4.2.4 Regulatory framework
6.4.2.5 Disease prevelance
6.4.3 Mexico
6.4.3.1 Key Country Dynamics
6.4.3.2 Mexico Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.4.3.3 Market Scenario
6.4.3.4 Regulatory Framework
6.4.3.5 Disease Prevelance
6.4.4 Argentina
6.4.4.1 Key country dynamics
6.4.4.2 Argentina polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.4.4.3 Market scenario
6.4.4.4 Regulatory framework
6.4.4.5 Disease prevelance
6.5 MEA
6.5.1 MEA Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.2 South Africa
6.5.2.1 Key Country Dynamics
6.5.2.2 South Africa Polymeric Biomaterials Market Estimates And Forecasts, 2018 - 2030 (USD Million)
6.5.2.3 Market Scenario
6.5.2.4 Regulatory Framework
6.5.2.5 Disease Prevelance
6.5.3 Saudi Arabia
6.5.3.1 Key country dynamics
6.5.3.2 Saudi Arabia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.3.3 Market scenario
6.5.3.4 Regulatory framework
6.5.3.5 Disease prevelance
6.5.4 UAE
6.5.4.1 Key country dynamics
6.5.4.2 UAE polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.4.3 Market scenario
6.5.4.4 Regulatory framework
6.5.4.5 Disease prevelance
6.5.5 Kuwait
6.5.5.1 Key country dynamics
6.5.5.2 Kuwait polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
6.5.5.3 Market scenario
6.5.5.4 Regulatory framework
6.5.5.5 Disease prevelance
Chapter 7 Competitive Landscape
7.1 Participant’s Overview
7.1.1 MEDTRONIC
7.1.1.1 Overview
7.1.1.2 Financial Performance
7.1.1.3 Product Benchmarking
7.1.1.4 Strategic Initiatives
7.1.2 STRYKER CORPORATION
7.1.2.1 Overview
7.1.2.2 Financial Performance
7.1.2.3 Product Benchmarking
7.1.2.4 Strategic Initiatives
7.1.3 BASF SE
7.1.3.1 Overview
7.1.3.2 Financial Performance
7.1.3.3 Product Benchmarking
7.1.3.4 Strategic Initiatives
7.1.4 EVONIK INDUSTRIES AG
7.1.4.1 Overview
7.1.4.2 Financial Performance
7.1.4.3 Product Benchmarking
7.1.4.4 Strategic Initiatives
7.1.5 DSM
7.1.5.1 Overview
7.1.5.2 Financial Performance
7.1.5.3 Product Benchmarking
7.1.5.4 Strategic Initiatives
7.1.6 BEZWADA BIOMEDICAL, LLC
7.1.6.1 Overview
7.1.6.2 Product Benchmarking
7.1.6.3 Strategic Initiatives
7.1.7 CORBION
7.1.7.1 Overview
7.1.7.2 Financial Performance
7.1.7.3 Product Benchmarking
7.1.7.4 Strategic Initiatives
7.1.8 VICTREX PLC (INVIBIO LTD.)
7.1.8.1 Overview
7.1.8.2 Financial Performance
7.1.8.3 Product Benchmarking
7.1.8.4 Strategic Initiatives
7.1.9 INTERNATIONAL POLYMER ENGINEERING
7.1.9.1 Overview
7.1.9.2 Product Benchmarking
7.1.9.3 Strategic Initiatives
7.1.10 COVALON TECHNOLOGIES LTD.
7.1.10.1 Overview
7.1.10.2 Financial Performance
7.1.10.3 Product Benchmarking
7.1.10.4 Strategic Initiatives
7.1.11 ABBOTT
7.1.11.1 Overview
7.1.11.2 Financial Performance
7.1.11.3 Product Benchmarking
7.1.11.4 Strategic Initiatives
7.1.12 ELIXIR MEDICAL
7.1.12.1 Overview
7.1.12.2 Product Benchmarking
7.1.12.3 Strategic Initiatives
7.1.13 REVA MEDICAL, LLC
7.1.13.1 Overview
7.1.13.2 Product Benchmarking
7.1.13.3 Strategic Initiatives
7.1.14 MERIL LIFE SCIENCES PVT. LTD.
7.1.14.1 Overview
7.1.14.2 Product Benchmarking
7.1.14.3 Strategic Initiatives
7.1.15 MICROPORT SCIENTIFIC CORPORATION
7.1.15.1 Overview
7.1.15.2 Financial Performance
7.1.15.3 Product Benchmarking
7.1.15.4 Strategic Initiatives
7.2 Participant Categorization
7.2.1 Polymeric Biomaterials Market Share Analysis, 2023
7.3 Strategy Mapping
7.3.1 Expansion
7.3.2 Acquisition
7.3.3 Collaborations & Partnerships
7.3.4 Product Launch
7.3.5 Others
Chapter 8 Analyst View
List of Tables
Table 1 List of Abbreviations
Table 2 Global polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 3 Global polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 4 Global polymeric biomaterials market, by region, 2018 - 2030 (USD Million)
Table 5 North America polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
Table 6 North America polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 7 North America polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 8 U.S. polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 9 U.S. polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 10 Canada polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 11 Canada polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 12 Europe polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
Table 13 Europe polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 14 Europe polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 15 Germany polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 16 Germany polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 17 UK polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 18 UK polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 19 France polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 20 France polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 21 Italy polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 22 Italy polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 23 Spain polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 24 Spain polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 25 Denmark polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 26 Denmark polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 27 Sweden polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 28 Sweden polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 29 Norway polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 30 Norway polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 31 Asia Pacific polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
Table 32 Asia Pacific polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 33 Asia Pacific polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 34 China polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 35 China polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 36 Japan polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 37 Japan polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 38 India polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 39 India polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 40 South Korea polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 41 South Korea polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 42 Australia polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 43 Australia polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 44 Thailand polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 45 Thailand polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 46 Latin America polymeric biomaterials market, by country, 2018 - 2030 (USD Million)
Table 47 Latin America polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 48 Latin America polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 49 Brazil polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 50 Brazil polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 51 Mexico polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 52 Mexico polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 53 Argentina polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 54 Argentina polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 55 Middle East & Africa polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 56 Middle East & Africa polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 57 South Africa polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 58 South Africa polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 59 Saudi Arabia polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 60 Saudi Arabia polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 61 UAE polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 62 UAE polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
Table 63 Kuwait polymeric biomaterials market, by product, 2018 - 2030 (USD Million)
Table 64 Kuwait polymeric biomaterials market, by application, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Polymeric biomaterials market segmentation
Fig. 2 Data analysis models
Fig. 3 Market formulation and validation
Fig. 4 Data validating & publishing
Fig. 5 Market research application
Fig. 6 Information procurement
Fig. 7 Primary research
Fig. 8 Value-chain-based sizing & forecasting
Fig. 9 QFD modeling for market share assessment
Fig. 10 Market formulation & validation
Fig. 11 Commodity flow analysis
Fig. 12 Market snapshot
Fig. 13 Segment snapshot
Fig. 14 Competitive landscape snapshot
Fig. 15 Biomaterials market value, 2023 (USD Billion)
Fig. 16 Market trends & outlook
Fig. 17 PESTEL analysis
Fig. 18 Porter’s five forces analysis
Fig. 19 Polymeric biomaterials market: Product outlook key takeaways
Fig. 20 Polymeric biomaterials market: Product movement analysis
Fig. 21 Global Polylactic Acid (PLA) market, 2018 - 2030 (USD Million)
Fig. 22 Global Polyglycolic Acid (PGA) market, 2018 - 2030 (USD Million)
Fig. 23 Global polyurethanes market, 2018 - 2030 (USD Million)
Fig. 24 Global Polytetrafluoroethylene (PTFE) & expanded Polytetrafluoroethylene (ePTFE) market, 2018 - 2030 (USD Million)
Fig. 25 Global Polyaryletheretherketone (PEEK) market, 2018 - 2030 (USD Million)
Fig. 26 Global Polydioxanone (PDO) market, 2018 - 2030 (USD Million)
Fig. 27 Global other products market, 2018 - 2030 (USD Million)
Fig. 28 Polymeric biomaterials market: Application outlook and key takeaways
Fig. 29 Polymeric biomaterials market: Application movement analysis
Fig. 30 Global cardiovascular market, 2018 - 2030 (USD Million)
Fig. 31 Global bioresorbable stents market, 2018 - 2030 (USD Million)
Fig. 32 Global vascular grafts market, 2018 - 2030 (USD Million)
Fig. 33 Global sensors market, 2018 - 2030 (USD Million)
Fig. 34 Global guidewires market, 2018 - 2030 (USD Million)
Fig. 35 Global implantable cardiac defibrillators market, 2018 - 2030 (USD Million)
Fig. 36 Global pacemakers market, 2018 - 2030 (USD Million)
Fig. 37 Global others market, 2018 - 2030 (USD Million)
Fig. 38 Global dental market, 2018 - 2030 (USD Million)
Fig. 39 Global tissue regeneration market, 2018 - 2030 (USD Million)
Fig. 40 Global dental implants market, 2018 - 2030 (USD Million)
Fig. 41 Global bone graft & substitutes market, 2018 - 2030 (USD Million)
Fig. 42 Global dental membranes market, 2018 - 2030 (USD Million)
Fig. 43 Global dental sutures market, 2018 - 2030 (USD Million)
Fig. 44 Global others market, 2018 - 2030 (USD Million)
Fig. 45 Global plastic surgery market, 2018 - 2030 (USD Million)
Fig. 46 Global facial wrinkle treatment market, 2018 - 2030 (USD Million)
Fig. 47 Global soft tissue fillers market, 2018 - 2030 (USD Million)
Fig. 48 Global craniofacial surgery market, 2018 - 2030 (USD Million)
Fig. 49 Global sutures market, 2018 - 2030 (USD Million)
Fig. 50 Global others market, 2018 - 2030 (USD Million)
Fig. 51 Global bioengineered skins market, 2018 - 2030 (USD Million)
Fig. 52 Global peripheral nerve repair market, 2018 - 2030 (USD Million)
Fig. 53 Global acellular dermal matrices market, 2018 - 2030 (USD Million)
Fig. 54 Global others market, 2018 - 2030 (USD Million)
Fig. 55 Global neurology market, 2018 - 2030 (USD Million)
Fig. 56 Global neural stem cell encapsulation market, 2018 - 2030 (USD Million)
Fig. 57 Global shunting systems market, 2018 - 2030 (USD Million)
Fig. 58 Global hydrogel scaffold market, 2018 - 2030 (USD Million)
Fig. 59 Global cortical neural prosthetics, 2018 - 2030 (USD Million)
Fig. 60 Global others market, 2018 - 2030 (USD Million)
Fig. 61 Global orthopedic market, 2018 - 2030 (USD Million)
Fig. 62 Global joint replacement biomaterials market, 2018 - 2030 (USD Million)
Fig. 63 Global tissue fixation products market, 2018 - 2030 (USD Million)
Fig. 64 Global sutures market, 2018 - 2030 (USD Million)
Fig. 65 Global others market, 2018 - 2030 (USD Million)
Fig. 66 Global orthobiologics Market, 2018 - 2030 (USD Million)
Fig. 67 Global viscosupplementation market, 2018 - 2030 (USD Million)
Fig. 68 Global spine biomaterials market, 2018 - 2030 (USD Million)
Fig. 69 Global others market, 2018 - 2030 (USD Million)
Fig. 70 Global other applications market, 2018 - 2030 (USD Million)
Fig. 71 Regional marketplace: Key takeaways
Fig. 72 Regional marketplace: Key takeaways
Fig. 73 North America polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 74 Key country dynamics
Fig. 75 U.S. polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 76 U.S. target disease prevalence
Fig. 77 Key country dynamics
Fig. 78 Canada polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 79 Canada target disease prevalence
Fig. 80 Europe polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 81 Key country dynamics
Fig. 82 Germany polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 83 Germany. target disease prevalence
Fig. 84 Key country dynamics
Fig. 85 UK polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 86 UK target disease prevalence
Fig. 87 Key country dynamics
Fig. 88 France polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 89 France target disease prevalence
Fig. 90 Key country dynamics
Fig. 91 Italy polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 92 Italy target disease prevalence
Fig. 93 Key country dynamics
Fig. 94 Spain polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 95 Spain target disease prevalence
Fig. 96 Key country dynamics
Fig. 97 Denmark polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 98 Denmark target disease prevalence
Fig. 99 Key country dynamics
Fig. 100 Sweden polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 101 Sweden target disease prevalence
Fig. 102 Key country dynamics
Fig. 103 Norway polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 104 Norway target disease prevalence
Fig. 105 Asia Pacific polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 106 Key country dynamics
Fig. 107 Japan polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 108 Japan target disease prevalence
Fig. 109 Key country dynamics
Fig. 110 China polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 111 China target disease prevalence
Fig. 112 Key country dynamics
Fig. 113 India polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 114 India target disease prevalence
Fig. 115 Key country dynamics
Fig. 116 Australia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 117 Australia target disease prevalence
Fig. 118 Key country dynamics
Fig. 119 Thailand polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 120 Key country dynamics
Fig. 121 South Korea polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 122 South Korea target disease prevalence
Fig. 123 Latin America polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 124 Key country dynamics
Fig. 125 Brazil polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 126 Brazil target disease prevalence
Fig. 127 Key country dynamics
Fig. 128 Mexico polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 129 Mexico target disease prevalence
Fig. 130 Key country dynamics
Fig. 131 Argentina polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 132 Argentina target disease prevalence
Fig. 133 MEA polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 134 Key country dynamics
Fig. 135 South Africa polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 136 South Africa target disease prevalence
Fig. 137 Key country dynamics
Fig. 138 Saudi Arabia polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 139 Saudi Arabia target disease prevalence
Fig. 140 Key country dynamics
Fig. 141 UAE polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 142 UAE target disease prevalence
Fig. 143 Key country dynamics
Fig. 144 Kuwait polymeric biomaterials market estimates and forecasts, 2018 - 2030 (USD Million)
Fig. 145 Kuwait target disease prevalence
Fig. 146 Market participant categorization
Fig. 147 Polymeric biomaterials market share analysis, 2023
Fig. 148 Strategic framework

Companies Profiled

  • MEDTRONIC
  • STRYKER CORPORATION
  • BASF SE
  • EVONIK INDUSTRIES AG
  • DSM
  • BEZWADA BIOMEDICAL, LLC
  • CORBION
  • VICTREX PLC (INVIBIO LTD.)
  • INTERNATIONAL POLYMER ENGINEERING
  • COVALON TECHNOLOGIES LTD.
  • ABBOTT
  • ELIXIR MEDICAL
  • REVA MEDICAL, LLC
  • MERIL LIFE SCIENCES PVT. LTD.
  • MICROPORT SCIENTIFIC CORPORATION

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages170
PublishedNovember 2023
Forecast Period2023 - 2030
Estimated Market Value ( USD ) in 2023 $ 51.13 Billion
Forecasted Market Value ( USD ) by 2030 $ 148.87 Billion
Compound Annual Growth Rate16.5%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Lower Extremity Implants Market Size, Share & Trends Analysis Report By Type (Knee, Hip), By Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials), By End-use, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Lower Extremity Implants Market Size, Share & Trends Analysis Report By Type (Knee, Hip), By Biomaterial (Metallic Biomaterials, Ceramic Biomaterials, Polymeric Biomaterials), By End-use, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From
Polymeric Biomaterials Global Market Report 2024 - Product Image

Polymeric Biomaterials Global Market Report 2024

  • Report
  • 175 Pages
  • Global
From
Polymeric Biomaterials Market - Product Image

Polymeric Biomaterials Market

  • Report
  • 200 Pages
  • Global
From
Polymeric Biomaterials Market 2024-2028 - Product Image

Polymeric Biomaterials Market 2024-2028

  • Report
  • 182 Pages
  • Global
From
Polymer Biomaterial Global Market Report 2024 - Product Image

Polymer Biomaterial Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From

About the Biomedical Polymer Market

The Biomedical Polymer market is a subset of the larger Biomaterials market, which encompasses a wide range of materials used in medical applications. Biomedical Polymers are synthetic or semi-synthetic polymers that are used in medical devices, implants, and drug delivery systems. These polymers are designed to be biocompatible, meaning they are non-toxic and do not cause an adverse reaction when in contact with living tissue. They are also designed to be biodegradable, meaning they can be broken down by the body over time. Biomedical Polymers are used in a variety of medical applications, including orthopedic implants, drug delivery systems, and wound dressings. They are also used in the manufacture of medical devices such as catheters, stents, and artificial organs. Some companies in the Biomedical Polymer market include BASF, DowDuPont, Evonik, Solvay, and Victrex. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.